Target intelligence / Profile preview

Amyloid Beta Fibril (Aβ Fibril)

Target
Aβ Fibril
Molecular classification
Protein aggregate, Amyloid protein
01

Overview

Amyloid beta (Aβ) fibrils are insoluble, fibrous protein aggregates formed by the self-assembly of amyloid beta peptides. These fibrils are a hallmark of Alzheimer's disease, accumulating as plaques in the brain and contributing to neurodegeneration. The formation and accumulation of Aβ fibrils is considered causative in Alzheimer’s pathology. Aβ fibrils display significant polymorphism—different arrangements at quaternary/protofilament levels—which may influence their biological activity and toxicity profiles. Fibrillar surfaces can catalyze the generation of toxic oligomeric species that damage neuronal cells. Amyloid beta interacts with several cell surface receptors on microglia and other cells including Scavenger receptors, Receptor for advanced glycation end products (RAGE), G-protein coupled receptors, Chemokine-like receptors and Toll-like receptors.

Other names
Amyloid plaquesAbeta aggregatesSenile plaques
02

Mechanism of action

Prevention of fibril formation and destabilization of pre-formed fibrils

03

Biological functions

Protein aggregationNeuroinflammationCellular dysfunctionCatalysis of toxic oligomer generation
04

Disease associations

Alzheimer's diseaseCerebral amyloid angiopathyNeurodegenerative disease
05

Safety considerations

Potential for off-target effects due to structural polymorphismRisk of amyloid-related imaging abnormalities (ARIA) with anti-amyloid therapiesComplexity of targeting multiple Aβ species (monomers, oligomers, fibrils)
06

Biomarkers

Aβ42/Aβ40 ratio in cerebrospinal fluidPlaque load on amyloid PET imaging

Beyond the preview

Go deeper on Amyloid Beta Fibril (Aβ Fibril).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid Beta Fibril (Aβ Fibril).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call